NCT06306846View on ClinicalTrials.gov

Neoadjuvant SBRT in Localized Advanced HNSCC

PHASE2RecruitingINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

October 1, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Head and Neck Squamous Carcinoma
Interventions
RADIATION

SBRT+immunochemotherpy

SBRT radiotherapy，followed with PD-1 monoclonal antibody and TP chemotherapy

DRUG

Immunochemotherapy

PD-1 monoclonal antibody and TP chemotheapy

DRUG

cetuximab+immunochemotharpy

PD-1 monoclonal antibody and TP chemotheapy combined with cetuximab

Trial Locations (1)

310022

RECRUITING

Zhejiang Cancer Hospital, Hangzhou

All Listed Sponsors
lead

Jiang Feng

OTHER